Legend Biotech Corporation (LEGN)

NASDAQ: LEGN · Real-Time Price · USD

23.90

-0.09 (-0.38%)

At close: Apr 24, 2026, 4:00 PM EDT

23.90

0.00 (0.00%)

After-hours: Apr 24, 2026, 5:31 PM EDT

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States of America Revenue	803.60M	579.05M
United States of America Revenue Growth	38.78%	114.55%
China Revenue	26.60M	320.00K
China Revenue Growth	8212.50%	78.77%
Europe Revenue	198.70M	47.87M
Europe Revenue Growth	315.06%	217.66%
Revenue (Total)	1.03B	627.30M
Revenue (Total) Growth	64.02%	120.03%

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
License Revenue	83.80M	138.40M
License Revenue Growth	-39.45%	293.64%
Collaboration Revenue	944.80M	482.58M
Collaboration Revenue Growth	95.78%	93.18%
Other Service Revenue	300.00K	6.26M
Other Service Revenue Growth	-95.20%	3395.53%
Revenue (Other)	-	59.00K
Revenue (Total)	1.03B	627.30M
Revenue (Total) Growth	64.02%	120.03%

Updated Mar 10, 2026. Data Source: Fiscal.ai.